As increasing demand for hemodialysis (HD) treatment incurs significant financial burden to
healthcare systems and ecological burden as well, novel therapeutic approaches as well as …

The prescription of hemodialysis (HD) in patients with incident end-stage kidney disease
(ESKD) is fundamentally empirical. The abrupt transition from nondialysis chronic kidney …

Twice-weekly hemodialysis, as part of incremental initiation, has reported benefits including
preservation of residual kidney function (RKF). To explore this, we initiated a randomized …

During the last decades, various strategies have been optimized to enhance clearance of a
variable spectrum of retained molecules to ensure hemodynamic tolerance to fluid removal …

SGLT-2i are the new standard of care for diabetic kidney disease (DKD), but previous
studies have not included patients on kidney replacement therapy (KRT). Due to their high …

Chronic kidney disease (CKD) patients require dialysis to manage the progressive
complications of uraemia. Yet, many physicians and patients do not recognize that dialysis …

We present a new edition of the Hemodialysis Center Guide. It is part of the program of
updating the Clinical Guides of the Spanish Society of Nephrology. It is a consensus …

Introduction The optimal haemodialysis (HD) prescription—frequency and dose—for
patients with incident dialysis-dependent kidney disease (DDKD) and substantial residual …

Introduction: The term incremental haemodialysis (HD) means that both dialysis dose and
frequency can be low at dialysis inception but should be progressively increased, to …

Background Thrice-weekly haemodialysis is the usual dose when starting renal replacement
therapy; however, this schedule is no longer appropriate since it does not consider residual …